US equities |
NVDA $240.22 ▲+0.55% SPCX $171.89 ▲+0.47% MU $1,059.28 ▼-0.44% MRVL $286.26 ▲+5.54% AMD $654.23 ▲+3.56% INTC $114.33 ▼-1.60% AVGO $378.63 ▲+4.45% TSLA $379.93 ▲+0.32%
FinancialContent

Articles published by Alpine Immune Sciences, Inc

News headline image
Alpine Immune Sciences to Present First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meeting
From Alpine Immune Sciences, Inc
Via Business Wire
Tickers ALPN
News headline image
Alpine Immune Sciences Set to Join Russell 3000® Index
From Alpine Immune Sciences, Inc
Via Business Wire
Tickers ALPN